BRIMOCHOL™ PF

DRUG2 trials

Sponsors

Visus Therapeutics

Conditions

Presbyopia

Phase 3

Safety and Efficacy Study of BRIMOCHOL™ PF and Carbachol PF in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia

CompletedNCT05135286

Visus TherapeuticsPresbyopia

Start: 2022-03-15End: 2025-03-13Updated: 2025-08-06

Safety and Efficacy Study BRIMOCHOL™ PF and Carbachol PF in Subjects With Emmetropic Phakic or Pseudophakic Presbyopia

CompletedNCT05270863

Visus TherapeuticsPresbyopia

Start: 2022-03-30End: 2023-04-10Updated: 2024-10-15